1. Home
  2. SYRE vs ASTE Comparison

SYRE vs ASTE Comparison

Compare SYRE & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • ASTE
  • Stock Information
  • Founded
  • SYRE 2013
  • ASTE 1972
  • Country
  • SYRE United States
  • ASTE United States
  • Employees
  • SYRE N/A
  • ASTE N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • ASTE Construction/Ag Equipment/Trucks
  • Sector
  • SYRE Health Care
  • ASTE Industrials
  • Exchange
  • SYRE Nasdaq
  • ASTE Nasdaq
  • Market Cap
  • SYRE 1.1B
  • ASTE 915.1M
  • IPO Year
  • SYRE 2016
  • ASTE N/A
  • Fundamental
  • Price
  • SYRE $16.26
  • ASTE $37.91
  • Analyst Decision
  • SYRE Buy
  • ASTE Hold
  • Analyst Count
  • SYRE 5
  • ASTE 1
  • Target Price
  • SYRE $55.00
  • ASTE $41.00
  • AVG Volume (30 Days)
  • SYRE 545.5K
  • ASTE 158.6K
  • Earning Date
  • SYRE 08-06-2025
  • ASTE 08-06-2025
  • Dividend Yield
  • SYRE N/A
  • ASTE 1.31%
  • EPS Growth
  • SYRE N/A
  • ASTE N/A
  • EPS
  • SYRE N/A
  • ASTE 0.66
  • Revenue
  • SYRE N/A
  • ASTE $1,325,300,000.00
  • Revenue This Year
  • SYRE N/A
  • ASTE $5.43
  • Revenue Next Year
  • SYRE N/A
  • ASTE $4.22
  • P/E Ratio
  • SYRE N/A
  • ASTE $59.87
  • Revenue Growth
  • SYRE N/A
  • ASTE 1.99
  • 52 Week Low
  • SYRE $10.91
  • ASTE $29.04
  • 52 Week High
  • SYRE $40.26
  • ASTE $43.35
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 48.34
  • ASTE 38.53
  • Support Level
  • SYRE $16.43
  • ASTE $38.99
  • Resistance Level
  • SYRE $17.70
  • ASTE $41.05
  • Average True Range (ATR)
  • SYRE 0.99
  • ASTE 1.11
  • MACD
  • SYRE -0.02
  • ASTE -0.09
  • Stochastic Oscillator
  • SYRE 37.17
  • ASTE 2.79

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

Share on Social Networks: